ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MCRB Seres Therapeutics Inc

1.15
0.04 (3.60%)
04 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Seres Therapeutics Inc MCRB NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.04 3.60% 1.15 09:56:13
Open Price Low Price High Price Close Price Previous Close
1.11 1.08 1.19 1.16 1.11
more quote information »

Recent News

Date Time Source Heading
09/4/202421:00BWSeres Therapeutics Announces Completion of Patient..
28/3/202422:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
19/3/202422:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
06/3/202402:18EDGAR2Form DEF 14A - Other definitive proxy statements
06/3/202402:13EDGAR2Form S-8 - Securities to be offered to employees in employee..
05/3/202423:05EDGAR2Form 8-K - Current report
05/3/202423:00BWSeres Therapeutics Reports Fourth Quarter and Full Year 2023..
05/3/202422:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
28/2/202423:00BWSeres Therapeutics to Host Fourth Quarter 2023 Financial..
27/2/202423:00BWSeres Therapeutics to Participate in Cowen 44th Annual..
26/2/202423:06EDGAR2Form 8-K - Current report
26/2/202423:00BWSeres Therapeutics Announces the Appointment of Marella..
24/2/202408:05EDGAR2Form PRE 14A - Other preliminary proxy statements
17/2/202413:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202413:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202413:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202413:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202413:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202408:01EDGAR2Form 8-K - Current report
17/1/202423:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
10/1/202423:00EDGAR2Form 8-K - Current report
10/1/202400:10DJNSeres Therapeutics Shares Rise 15% After Getting FDA..
09/1/202423:05EDGAR2Form 8-K - Current report
09/1/202423:00BWSeres Therapeutics Announces VOWST™ Commercial Launch Update..
05/1/202408:00BWSeres Therapeutics to Participate in the 42nd Annual J.P...
03/1/202408:05EDGAR2Form 8-K - Current report
08/12/202311:46BWSeres Therapeutics Announces Presentation of Preliminary..
29/11/202301:18BWSeres Therapeutics to Participate in the Piper Sandler 35th..
28/11/202311:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202322:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
03/11/202301:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202322:05EDGAR2Form 8-K - Current report
02/11/202322:00BWSeres Therapeutics Reports Third Quarter 2023 Financial..
02/11/202301:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
01/11/202312:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202312:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202312:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202312:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202312:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202312:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202308:30BWSeres Therapeutics to Announce Third Quarter 2023 Results on..
12/10/202322:00BW Seres Therapeutics to Highlight VOWST™ Data at IDWeek
06/10/202322:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
04/10/202322:00EDGAR2Form 8-K - Current report
11/9/202320:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
08/9/202321:00BWSeres Therapeutics Reports Inducement Grants Under Nasdaq..
08/9/202300:00BWSeres Therapeutics to Participate in the Morgan Stanley 21st..
29/8/202323:00PRNUSInvaio achieves first registration for citrus greening..
16/8/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
09/8/202306:07EDGAR2Form S-3 - Registration statement under Securities Act of..

Your Recent History

Delayed Upgrade Clock